Search

everythinglearnresearchcommunity

for

Search:↓

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Androgenic steroids can slow down or stop the growth of certain skin fungi.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

A boy's early puberty caused by a testicular tumor returned to normal after surgery.

Hair loss in postmenopausal woman caused by ovarian issue.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Male hormones control a specific gene in hamster skin, with different hormones having varying effects.

Sex steroids, especially progesterone, can slow down the growth of mouse melanoma cells.

Measuring 17-hydroxyprogesterone in hair can help monitor androgen levels in people with congenital adrenal hyperplasia.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Untreated congenital adrenal hyperplasia can lead to complications like stroke and needs glucocorticoid treatment.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Most women with polycystic ovary syndrome (PCOS) have menstrual issues, infertility, acne, and excessive body hair, with the most common type being the non-androgenic phenotype.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.